<?xml version="1.0" encoding="UTF-8"?>
<p>Disabilities secondary to skin conditions are substantial, and skin diseases elicit a huge burden in the global context of health, affecting about 1.9 billion people at any given time [
 <xref rid="B1-antibiotics-09-00909" ref-type="bibr">1</xref>,
 <xref rid="B2-antibiotics-09-00909" ref-type="bibr">2</xref>]. In 2017, they were ranked in the top 25 leading causes of Disability Adjusted Life Years (DALYs), accounting for 44.1 million DALYs worldwide [
 <xref rid="B3-antibiotics-09-00909" ref-type="bibr">3</xref>]. Skin and soft tissue infections (SSTIs) contribute towards 65% of the DALYs of the total skin diseases. SSTIs commonly affect children who live in tropical and subtropical climates, particularly within resource-poor communities, where they affect 21â€“87% of this age group [
 <xref rid="B1-antibiotics-09-00909" ref-type="bibr">1</xref>].
</p>
